blank
blank
National Mirror Groups bring national needs and examples of good practice into ERDERA’s annual work plans, share ERDERA outputs with organisations and communities at country level, and enable direct peer-to-peer learning between countries.​

National Mirror Groups (NMGs)

What are NMGs?

National Mirror Groups (NMGs)are national networks bringing together key peopleand organisations involved in rare diseases — including patients and patientorganisations, clinicians, researchers, funders, and national authorities.​
​
They are central to ERDERA’s national-international alignment work, helping toconnect national activity with research and knowledge at European and global levels.

blank

NMGs play a two-fold role:

  • Strengthen and coordinate the national rare disease community, building onexisting structures where these exist or creating new ones where needed.
  • Driving two-way engagementbetween national communities and largeinternational initiatives — most notably ERDERA — and with wider cross‑disease orpan‑European collaborations.

Objectives of the NMGs​

Build and/or sustain a cohesive rare disease community at national level​
Support the development and implementation of a national plan or strategy for rare disease ​
Channel national needs and good practices into ERDERA​
Disseminate and help implement ERDERA outputs at home​
Foster peer-to-peer exchange between countries ​
blank

Why does having a NMG matter?​

National Mirror Groups (NMGs)facilitate the integration of national prioritiesand best practices into ERDERA’s annual work plans.They disseminate ERDERA’s findings, tools, and opportunities within their respective countries, while fostering peer-to-peercollaboration and practical knowledge exchange across countries. NMGs can foster stronger collaborations betweenparticularcountries or groups of countries, depending on size, geography, or other commonalities.

For people living with rare diseases, this alignment is highly beneficial: itminimises redundancy, streamlines participation ininternational studies and clinical trials, and enables research outcomes, tools, and funding to reach a broader range of countries,including those with emerging research and policy frameworks for rare diseases.

We aimto set upa National Mirror Group ineverycountry involved in ERDERA. Check if yourcountry has one already.​

Want to learn more?

Visit ourdedicated pageabout National Mirror Groups, where you will find updates, essential details, contactinformation, and much more!​
​
Other relevant resources:

You might also be interested in

webinar series ERDERA

Introductory webinar: Situating ethics in the research continuum

July 24 @ 3:00 pm - 4:00 pm
This webinar will present a theoretical framework for situating ethics across research activities. The framework will then be brought to life through a relevant case study discussion, giving participants a concrete reference point for the episodes ahead.
State of the art rare disease country reports ERDERA

State of the art 2026 rare disease country report: Poland

This 2026 country report outlines the policy, research, care and support landscape for rare diseases in Poland.
NMG workshop 2026

ERDERA National Mirror Groups workshop: Creating, evolving and utilising national registries to advance rare disease research

Held in Riga on 9–10 June, the workshop brought National Mirror Group experts, researchers, clinicians and policymakers together to exchange practical lessons on how national rare disease registries can better support research and alignment across countries.
2

ERDERA launches Clinical Trial Call 2026 to advance early‑phase clinical trials for rare diseases

ERDERA (the European Rare Diseases Research Alliance) has opened its Clinical Trial Call to support multinational early-phase clinical trials in rare diseases. The call will fund studies designed to generate robust clinical evidence, strengthen regulatory readiness and make rare disease trials more feasible across countries.

ERDERA's

search form